Stockholm-based biotech company BioLamina has secured a €20 million financing commitment from the European Investment Bank (EIB) to scale its technologies supporting next-generation cell therapies.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?